Search Results - Piedagne, J.-M.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    LBP-032 - Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II/III trial

    LBP-032 - Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-... by Andrieux-Meyer, I., Tan, S.-S., Salvadori, N., Simon, F., Cressey, T.R., Said, H.R.H.M., Hassan, M.R.A., Omar, H., Tee, H.P., Chan, W.-K., Goh, K.L., Omar, S.F.S., Kamarulzaman, A., Kumar, S., Thongsawat, S., Thetket, K., Avihingsanon, A., Khemnark, S., Thanprasertsuk, S., Piedagne, J.-M., Brenner, J., Siva, S., Asimah, N., Da Silva, N., Pecoul, B., Lallemant, M., Murad, S.

    Published in Journal of hepatology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II/III trial

    Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in noncirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II... by Andrieux-Meyer, I., Tan, S.-S., Salvadori, N., Simon, F., Cressey, T.R., Said, H.R.H.M., Hassan, M.R.A., Omar, H., Tee, H.P., Chan, W.-K., Goh, K.L., Omar, S.F.S., Kamarulzaman, A., Kumar, S., Thongsawat, S., Thetket, K., Avihingsanon, A., Khemnark, S., Thanprasertsuk, S., Piedagne, J.-M., Brenner, J., Siva, S., Asimah, N., Da Silva, N., Pecoul, B., Lallemant, M., Murad, S.

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: